ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,159.43
      -0.05%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Javelin Pharmaceuticals (JAV)

      7. Javelin Pharmaceuticals (JAV) News

      JAV

      Javelin Pharmaceuticals (JAV)

      Javelin Pharmaceuticals
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:JAV
      DateTimeSourceHeadlineSymbolCompany
      07/07/20106:00AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:JAVJavelin Pharmaceuticals
      07/07/20106:00AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:JAVJavelin Pharmaceuticals
      07/07/20106:00AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:JAVJavelin Pharmaceuticals
      07/06/20101:14PMEdgar (US Regulatory)(25-NSE)AMEX:JAVJavelin Pharmaceuticals
      07/02/20104:39PMEdgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)AMEX:JAVJavelin Pharmaceuticals
      07/02/20104:31PMEdgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)AMEX:JAVJavelin Pharmaceuticals
      07/02/20104:29PMEdgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)AMEX:JAVJavelin Pharmaceuticals
      07/02/20104:24PMEdgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)AMEX:JAVJavelin Pharmaceuticals
      07/02/20104:20PMEdgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)AMEX:JAVJavelin Pharmaceuticals
      07/02/20104:19PMEdgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)AMEX:JAVJavelin Pharmaceuticals
      07/02/20103:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
      07/02/20103:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
      07/02/20103:24PMEdgar (US Regulatory)Current report filing (8-K)AMEX:JAVJavelin Pharmaceuticals
      07/02/20103:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
      07/02/20103:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
      07/02/20103:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
      07/02/20103:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
      07/02/20103:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
      07/01/20105:20PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)AMEX:JAVJavelin Pharmaceuticals
      07/01/20102:59PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)AMEX:JAVJavelin Pharmaceuticals
      07/01/20108:05AMBusiness WireJavelin Pharmaceuticals, Inc. Announces Successful Completion of Tender Offer for Its Common Stock by Hospira, Inc.AMEX:JAVJavelin Pharmaceuticals
      06/30/20106:50AMGlobeNewswire Inc.Javelin Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.comAMEX:JAVJavelin Pharmaceuticals
      06/29/20103:42PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)AMEX:JAVJavelin Pharmaceuticals
      06/21/20106:23PMDow Jones News2nd UPDATE: Business Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
      06/21/20104:08PMDow Jones NewsUPDATE: Business Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
      06/21/201010:33AMDow Jones NewsBusiness Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
      06/21/20108:30AMBusiness WireNews Release Service Inadvertently Issues Hoax Press Release Identifying Javelin Pharmaceuticals as IssuerAMEX:JAVJavelin Pharmaceuticals
      06/17/20104:50PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)AMEX:JAVJavelin Pharmaceuticals
      06/17/20104:19PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)AMEX:JAVJavelin Pharmaceuticals
      06/11/20104:55PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)AMEX:JAVJavelin Pharmaceuticals
       Showing the most relevant articles for your search:AMEX:JAV